Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (231-240 of 3,133) with videos related to

Pageof 314
Sort By:
Cytotherapy|July 10, 2003
A non-viral gene delivery system designed for clinical useJ C Fratantoni, S Dzekunov, V Singh, et al.
Cytotherapy|July 10, 2003
Artificial T-cell receptorsM Pule, H Finney, A Lawson
Cytotherapy|July 10, 2003
Suicide genes as safety switches in T lymphocytesK C Straathof, D M Spencer, R E Sutton, et al.
Cytotherapy|July 10, 2003
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15H-J Wagner, U Sili, B Gahn, et al.
Cytotherapy|July 10, 2003
Synthesis and release of human (pro)insulin in human BM progenitor cellsR Y L Wong, R Lindeman, B E Tuch
Cytotherapy|June 15, 2019
Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizonMichael Mendicino, Yong Fan, Deborah Griffin, et al.
Cytotherapy|June 30, 2019
High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell countsMehul Gupta, Sunand Kannappan, Amit Kalra, et al.
Cytotherapy|July 6, 2019
Biomarkers of bone healing induced by a regenerative approach based on expanded bone marrow-derived mesenchymal stromal cellsDonatella Granchi, Gabriela Ciapetti, Enrique Gómez-Barrena, et al.
Cytotherapy|July 8, 2019
Generation of Zika virus-specific T cells from seropositive and virus-naïve donors for potential use as an autologous or "off-the-shelf" immunotherapeuticRyo Hanajiri, Gelina M Sani, Patrick J Hanley, et al.
Cytotherapy|April 13, 2019
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ productionFriedrich Erhart, Tamara Weiss, Simone Klingenbrunner, et al.
Pageof 314

Showing results (231-240 of 3,133) with videos related to

Sort By:
Pageof 314
Cytotherapy|July 10, 2003
A non-viral gene delivery system designed for clinical useJ C Fratantoni, S Dzekunov, V Singh, et al.
Cytotherapy|July 10, 2003
Artificial T-cell receptorsM Pule, H Finney, A Lawson
Cytotherapy|July 10, 2003
Suicide genes as safety switches in T lymphocytesK C Straathof, D M Spencer, R E Sutton, et al.
Cytotherapy|July 10, 2003
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15H-J Wagner, U Sili, B Gahn, et al.
Cytotherapy|July 10, 2003
Synthesis and release of human (pro)insulin in human BM progenitor cellsR Y L Wong, R Lindeman, B E Tuch
Cytotherapy|June 15, 2019
Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizonMichael Mendicino, Yong Fan, Deborah Griffin, et al.
Cytotherapy|June 30, 2019
High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell countsMehul Gupta, Sunand Kannappan, Amit Kalra, et al.
Cytotherapy|July 6, 2019
Biomarkers of bone healing induced by a regenerative approach based on expanded bone marrow-derived mesenchymal stromal cellsDonatella Granchi, Gabriela Ciapetti, Enrique Gómez-Barrena, et al.
Cytotherapy|July 8, 2019
Generation of Zika virus-specific T cells from seropositive and virus-naïve donors for potential use as an autologous or "off-the-shelf" immunotherapeuticRyo Hanajiri, Gelina M Sani, Patrick J Hanley, et al.
Cytotherapy|April 13, 2019
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ productionFriedrich Erhart, Tamara Weiss, Simone Klingenbrunner, et al.
Pageof 314